Summary of New Strategy Could Eliminate Aging Cells:
Senescent cells accumulate in the body as we age and have been linked to various age-related diseases. Researchers at Massachusetts General Hospital have discovered that CD4+ T cells, responsible for keeping senescent cells in check, target cells that express a protein from the human cytomegalovirus. This means that the immune response to the virus helps maintain a balance of aging organs by eliminating the senescent cells. The study could lead to new therapies for cancer, fibrosis, and degenerative illnesses by boosting the anti-viral immune response.
*****
A Potential New Strategy to Combat Age-Related Illnesses
As we age, our bodies can accumulate aging, or senescent cells, which have ceased division but don’t die. Senescent cells are cells that have stopped dividing and can no longer perform their normal functions. They accumulate with age and have been linked to several age-related diseases, including arthritis, cardiovascular disease, and neurodegeneration. These cells can lead to chronic inflammation, which can contribute to developing diseases such as cancer and various degenerative disorders.
Removing Senescent Cells
Studies in mice have shown that removing senescent cells from aging tissues can result in a restored tissue balance and a prolonged healthy lifespan. Now, a team of researchers at Massachusetts General Hospital, a founding member of Mass General Brigham, has discovered that the immune response to a common virus in human tissues can detect and eliminate senescent cells in the skin.
The Role of Killer CD4+ T Cells
Experiments suggested that once a person becomes elderly, specific immune cells called killer CD4+ T cells keep senescent cells from increasing. Indeed, higher numbers of killer CD4+ T cells in tissue samples were associated with reduced senescent cells in old skin.
The Role of Cytomegalovirus Antigen
When they assessed how killer CD4+ T cells keep senescent cells in check, the researchers found that aging skin cells express a protein, or antigen, produced by human cytomegalovirus. This pervasive herpes virus establishes lifelong latent infection in most humans without symptoms. By saying this protein, senescent cells become targets for attack by killer CD4+ T cells.
Possible Clinical Applications
These findings, which highlight the beneficial function of viruses living in our bodies, could have a variety of clinical applications. “Our research enables a new therapeutic approach to eliminate aging cells by boosting the anti-viral immune response,” says senior author Shawn Demehri, MD, Ph.D., director of the High-Risk Skin Cancer Clinic at MGH and an associate professor of Dermatology at Harvard Medical School. “We are interested in utilizing the immune response to cytomegalovirus as a therapy to eliminate senescent cells in diseases like cancer, fibrosis, and degenerative diseases.”
Future Directions
Demehri notes that the work may also lead to advances in cosmetic dermatology, such as developing new treatments to make skin look younger. The Burroughs Wellcome Fund and Shiseido Co. Ltd funded the study.
Conclusion
This study could serve as a potential game-changer in the domain of anti-aging. Boosting the immune response is a relatively harmless approach to rejuvenating cells and could have potential clinical and cosmetic applications. Future research will reveal whether these immune cells can be influenced to maintain/restore tissue balance in age-related diseases. Currently, anti-aging therapies focus primarily on supplements and topical skin care, but this new approach could lead to more comprehensive ways of rejuvenating the body at the cellular level.
